These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15735429)

  • 1. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency.
    Lytle C; Tod TJ; Vo KT; Lee JW; Atkinson RD; Straus DS
    Inflamm Bowel Dis; 2005 Mar; 11(3):231-43. PubMed ID: 15735429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
    Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
    Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
    Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
    J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
    Shah YM; Morimura K; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
    Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
    Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.
    Pedersen G; Brynskov J
    Am J Gastroenterol; 2010 Jul; 105(7):1595-603. PubMed ID: 20087330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
    Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
    Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
    Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
    Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice.
    Cheng Y; Li S; Wang M; Cheng C; Liu R
    Med Sci Monit; 2018 Dec; 24():9045-9053. PubMed ID: 30544130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone ameliorates senescence-like phenotypes in a cellular photoaging model.
    Chen L; Bi B; Zeng J; Zhou Y; Yang P; Guo Y; Zhu J; Yang Q; Zhu N; Liu T
    J Dermatol Sci; 2015 Mar; 77(3):173-81. PubMed ID: 25703056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndrome.
    Li X; Xu B; Wang Y; Wei L
    Int J Clin Exp Pathol; 2014; 7(8):4886-94. PubMed ID: 25197359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
    Gonon AT; Bulhak A; Labruto F; Sjöquist PO; Pernow J
    Basic Res Cardiol; 2007 Jan; 102(1):80-9. PubMed ID: 16900441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.